Coronary Artery Disease (CAD) Epidemiology Forecast 2025-2034

In 2022, there were 315 million people worldwide living with coronary artery disease (CAD), as per a study published in the Journal of the American College of Cardiology (2024). The age-standardized prevalence of coronary artery disease in 2022 was 3605 per 100,000 people. Coronary artery disease (CAD) epidemiology forecast indicates that the regions with the highest rates of coronary artery disease were Central Europe, Eastern Europe, and Central Asia, with a rate of 8019 per 100,000. On the other hand, South Asia had the lowest rate, at 2393 per 100,000.

Coronary Artery Disease (CAD) Epidemiology Forecast Report Coverage

The “Coronary Artery Disease (CAD) Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of coronary artery disease (CAD). It projects the future incidence and prevalence rates of coronary artery disease (CAD) cases across various populations. The study covers age and type as major determinants of the coronary artery disease (CAD) population. The report highlights patterns in the prevalence of coronary artery disease (CAD) over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on coronary artery disease (CAD) epidemiology in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Coronary Artery Disease (CAD) Understanding: Disease Overview

In coronary artery disease (CAD), coronary arteries become narrowed or blocked due to the buildup of fatty deposits (plaque) in the artery walls. The plaque is made up of cholesterol, fat, and other substances found in the blood. Over time, the plaque can harden and narrow the arteries, restricting blood flow to the heart. High cholesterol, high blood pressure, smoking, diabetes, and obesity are some of the risk factors for coronary artery disease.

Diagnosis includes tests like electrocardiograms (ECGs), stress tests, coronary angiography, and advanced imaging techniques, among others. Studies suggest that preventive strategies such as a balanced diet, regular exercise, quitting smoking, and managing underlying conditions can significantly lower the risk of coronary artery disease (CAD).

Coronary Artery Disease (CAD) Epidemiology Perspective

The Coronary Artery Disease (CAD) epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for coronary artery disease (CAD) epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for the disease and their trends. the coronary artery disease (CAD) detailed epidemiology segmentation is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• Coronary artery disease (CAD) is a major global health issue, ranking as the third leading cause of mortality across the globe. Various studies estimate that the condition is associated with approximately 17.8 million deaths worldwide annually.
• As per a report from the American Heart Association published in Circulation (2023), approximately 1 in 20 adults, or 5% of the population aged 20 and older, are living with coronary artery disease in the United States.
• In 2022, there were 315 million cases of coronary artery disease (CAD) worldwide, with the age-standardized prevalence estimated to be 3,605 per 100,000 people, according to a study published in the Journal of the American College of Cardiology (2024).
• The prevalence of coronary artery disease increases after the age of 35 in both men and women. By age 40, the lifetime risk is 49% for men and 32% for women .
• A 2020 prospective study reported that patients with non-alcoholic fatty liver disease (NAFLD) had a more than 2 times higher risk of developing cardiovascular events, including coronary artery disease (CAD), while those with liver fibrosis had a 4 times increased risk of cardiovascular events.

Country-wise Coronary Artery Disease (CAD) Epidemiology Segment

The coronary artery disease (CAD) epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of coronary artery disease (CAD) varies between countries owing to differences in lifestyle and diet, availability of healthcare services, genetic predispositions, family history of heart disease, and national and regional health policies, among others. In the United Kingdom, about 2.3 million people are affected by coronary heart disease.

Coronary Artery Disease (CAD): Treatment Overview

The treatment approach for coronary artery disease often involves lifestyle changes, medications, and, in some cases, medical procedures. Lifestyle modifications, including a healthy diet, regular physical activity, smoking cessation, and weight management, are initially recommended for managing and improving heart health. Several coronary artery disease (CAD) therapeutics, such as statins, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitor drugs, are commonly prescribed to treat the condition. Aspirin or blood thinners also help in reducing the risk of blood clots, which can block narrowed arteries and cause heart attacks.

Key Questions Answered

• What are the key findings of coronary artery disease (CAD) epidemiology in the 8 major markets?
• What will be the total number of patients with coronary artery disease (CAD) across the 8 major markets during the forecast period?
• What was the country-wise coronary artery disease (CAD) epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of coronary artery disease (CAD) patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of coronary artery disease (CAD) during the forecast period of 2025-2034?
• What are the currently available treatments in the coronary artery disease (CAD) market?
• What are the disease risks, signs, symptoms, and unmet needs of coronary artery disease (CAD)?

Scope of the Coronary Artery Disease (CAD) Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of coronary artery disease (CAD) based on several factors.
• The Coronary Artery Disease (CAD) Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The coronary artery disease (CAD) report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

This product will be delivered within 3-5 business days.